Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Brennan · SciRah

Researcher profile · Semantic Scholar

D. Brennan

Share profile

D. Brennan — researcher profile on SciRah

h-index: 39
Works: 120
Citations: 10K

Most-cited papers

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.
Deepak L. Bhatt, K. Fox, W. Hacke, P. Berger +22 more
2006New England Journal of Medicine2,558 citations Open access
Semantic Scholar
Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial.
S. Nicholls, R. Puri, T. Anderson, C. Ballantyne +15 more
2016Journal of the American Medical Association (JAMA)1,098 citations Open access
Semantic Scholar
Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk.
Tamali Bhattacharyya, S. Nicholls, E. Topol, Renliang Zhang +10 more
2008Journal of the American Medical Association (JAMA)557 citations Open access
Semantic Scholar
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial.
S. Nissen, E. Stroes, Ricardo E. Dent-Acosta, R. Rosenson +14 more
2016Journal of the American Medical Association (JAMA)495 citations Open access
Semantic Scholar
Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial.
Stephen J. Nicholls, J. Kastelein, Gregory G. Schwartz, Dianna Bash +10 more
2014Journal of the American Medical Association (JAMA)328 citations
Semantic Scholar
Bleeding Complications With Dual Antiplatelet Therapy Among Patients With Stable Vascular Disease or Risk Factors for Vascular Disease: Results From the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) Trial
P. Berger, Deepak L. Bhatt, V. Fuster, P. Steg +7 more
2010Circulation231 citations Open access
Semantic Scholar
Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study.
A. Ioachimescu, D. Brennan, B. Hoar, S. Hazen +1 more
2008Arthritis & Rheumatism198 citations
Semantic Scholar
Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary intervention.
S. Steinhubl, P. Berger, D. Brennan, E. Topol
2006Journal of the American College of Cardiology197 citations Open access
Semantic Scholar
The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
Patricia J. M. Best, S. Steinhubl, P. Berger, Arijit Dasgupta +4 more
2008American Heart Journal190 citations
Semantic Scholar
Hypothyroidism and Moderate Subclinical Hypothyroidism Are Associated with Increased All-Cause Mortality Independent of Coronary Heart Disease Risk Factors: A PreCIS Database Study
C. McQuade, Mario Skugor, D. Brennan, B. Hoar +2 more
2011Thyroid186 citations
Semantic Scholar
Aspirin to Prevent Cardiovascular Disease: The Association of Aspirin Dose and Clopidogrel With Thrombosis and Bleeding
S. Steinhubl, Deepak L. Bhatt, D. Brennan, G. Montalescot +4 more
2009Annals of Internal Medicine186 citations
Semantic Scholar
TREATMENT STRATEGIES IN PATIENTS WITH STATIN INTOLERANCE: THE CLEVELAND CLINIC EXPERIENCE
W. Mampuya, D. Frid, Michael V. Rocco, Julie C. Huang +3 more
2013American Heart Journal173 citations Open access
Semantic Scholar
Abstract 3287: Lack of Evidence of a Clopidogrel-Statin Interaction in the CHARISMA Trial
J. Saw, D. Brennan, S. Steinhubl, E. Topol
2006141 citations
Semantic Scholar
Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis
G. Ducrocq, J. Wallace, G. Baron, P. Ravaud +7 more
2010European Heart Journal139 citations Open access
Semantic Scholar
The Lipid Accumulation Product and All‐cause Mortality in Patients at High Cardiovascular Risk: A PreCIS Database Study
A. Ioachimescu, D. Brennan, B. Hoar, B. J. Hoogwerf
2010Obesity139 citations
Semantic Scholar
Abstract 3999: Baseline Proton Pump Inhibitor Use is Associated with Increased Cardiovascular Events With and Without the Use of Clopidogrel in the CREDO Trial
Steven P. Dunn, Tracy E. Macaulay, D. Brennan, C. Campbell +5 more
2008139 citations
Semantic Scholar
Effect of Evolocumab on Coronary Plaque Composition.
S. Nicholls, R. Puri, T. Anderson, C. Ballantyne +14 more
2018Journal of the American College of Cardiology136 citations Open access
Semantic Scholar
Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease.
M. Shishehbor, Renliang Zhang, H. Medina, M. Brennan +4 more
2006Free Radical Biology & Medicine131 citations Open access
Semantic Scholar
Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients.
S. Nissen, V. Menon, Stephen J. Nicholls, D. Brennan +11 more
2023Journal of the American Medical Association (JAMA)128 citations Open access
Semantic Scholar
The Risk of Major NSAID Toxicity with Celecoxib, Ibuprofen, or Naproxen: A Secondary Analysis of the PRECISION Trial.
D. Solomon, M. E. Husni, P. Libby, Neville D. Yeomans +7 more
2017American Journal of Medicine116 citations
Semantic Scholar
Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial.
A. Lincoff, M. Roe, P. Aylward, J. Galla +22 more
2014European Heart Journal97 citations Open access
Semantic Scholar
Impact of Exercise on Heart Rate Recovery
M. Jolly, D. Brennan, L. Cho
2011Circulation92 citations Open access
Semantic Scholar
Lipoprotein(a) levels and long-term cardiovascular risk in the contemporary era of statin therapy
Stephen J. Nicholls, W. H. Wilson Tang, H. Scoffone, D. Brennan +3 more
2010Journal of Lipid Research87 citations Open access
Semantic Scholar
Remnant cholesterol, coronary atheroma progression and clinical events in statin-treated patients with coronary artery disease
M. Elshazly, P. Mani, S. Nissen, D. Brennan +7 more
2019European Journal of Preventive Cardiology84 citations
Semantic Scholar
Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
H. Aronow, S. Steinhubl, D. Brennan, P. Berger +1 more
2009American Heart Journal82 citations
Semantic Scholar
Comparative Effects of Low-Dose Rosuvastatin, Placebo and Dietary Supplements on Lipids and Inflammatory Biomarkers.
L. Laffin, D. Bruemmer, Michelle Garcia, D. Brennan +8 more
2022Journal of the American College of Cardiology79 citations Open access
Semantic Scholar
An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial.
Thomas H. Wang, Deepak L. Bhatt, K. Fox, S. Steinhubl +9 more
2007European Heart Journal77 citations
Semantic Scholar
Effect of Clopidogrel plus ASA vs. ASA Early after TIA and Ischaemic Stroke: A Substudy of the CHARISMA Trial
G. Hankey, S. Johnston, J. Easton, W. Hacke +6 more
2011International Journal of Stroke72 citations
Semantic Scholar
Fate of individuals with ischemic amputations in the REACH Registry: three-year cardiovascular and limb-related outcomes.
M. T. Abola, Deepak L. Bhatt, S. Duval, P. Cacoub +6 more
2012Atherosclerosis59 citations
Semantic Scholar
Canakinumab to reduce deterioration of cardiac and respiratory function in SARS‐CoV‐2 associated myocardial injury with heightened inflammation (canakinumab in Covid‐19 cardiac injury: The three C study)
C. Sheng, D. Sahoo, S. Dugar, R. Prada +10 more
2020Clinical Cardiology54 citations Open access
Semantic Scholar
Gender Differences in Utilization of Effective Cardiovascular Secondary Prevention: A Cleveland Clinic Prevention Database Study
L. Cho, B. Hoogwerf, Julie C. Huang, D. Brennan +1 more
2008Journal of Women's Health53 citations Open access
Semantic Scholar
Risk Prediction with Serial Myeloperoxidase Monitoring in Patients with Acute Chest Pain
Stephen J. Nicholls, W. H. Wilson Tang, D. Brennan, M. Brennan +3 more
2011Clinical Chemistry51 citations Open access
Semantic Scholar
Is There a Clinically Significant Interaction between Calcium Channel Antagonists and Clopidogrel? Results from the CREDO Trial
CHRISTOPHER W. Good, S. Steinhubl, D. Brennan, A. Lincoff +2 more
2012Circulation. Cardiovascular Interventions39 citations Open access
Semantic Scholar
Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
T. S. Hall, J. Hallén, M. Krucoff, M. Roe +4 more
2015American Heart Journal37 citations
Semantic Scholar
Clinical Utility of Waist Circumference in Predicting All‐cause Mortality in a Preventive Cardiology Clinic Population: A PreCIS Database Study
H. Bajaj, D. Brennan, B. J. Hoogwerf, K. Doshi +1 more
2009Obesity36 citations
Semantic Scholar
Association of SF-36 with coronary artery disease risk factors and mortality: a PreCIS study.
Jianping Zhang, L. Pozuelo, D. Brennan, B. Hoar +1 more
2009Preventive Cardiology35 citations Open access
Semantic Scholar
Peroxisome proliferator-activated receptor gamma agonists for the Prevention of Adverse events following percutaneous coronary Revascularization--results of the PPAR study.
Deepak L. Bhatt, D. Chew, C. Grines, D. Mukherjee +15 more
2007American Heart Journal35 citations
Semantic Scholar
Relationship Between Baseline Inflammatory Markers, Antiplatelet Therapy, and Adverse Cardiac Events After Percutaneous Coronary Intervention: An Analysis From the Clopidogrel for the Reduction of Events During Observation Trial
Kristofer Dosh, Peter B. Berger, S. Marso, F. van Lente +4 more
2009Circulation. Cardiovascular Interventions34 citations Open access
Semantic Scholar
Effect of Clopidogrel on the Rate and Functional Severity of Stroke Among High Vascular Risk Patients: A Prespecified Substudy of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) Trial
G. Hankey, W. Hacke, J. Easton, S. Johnston +5 more
2010Stroke32 citations Open access
Semantic Scholar
Comparing SF-36® scores versus biomarkers to predict mortality in primary cardiac prevention patients.
Rony N. Lahoud, Vasutakarn Chongthammakun, Yuping Wu, N. Hawwa +2 more
2017European journal of internal medicine30 citations
Semantic Scholar
The impact of left ventricular size on response to cardiac resynchronization therapy.
J. Rickard, D. Brennan, David O. Martin, E. Hsich +5 more
2011American Heart Journal29 citations
Semantic Scholar
Correlation of High‐Density Lipoprotein–Associated Paraoxonase 1 Activity With Systemic Inflammation, Disease Activity, and Cardiovascular Risk Factors in Psoriatic Disease
M. E. Husni, W. H. Wilson Tang, M. Lucke, U. M. Chandrasekharan +2 more
2018Arthritis & Rheumatology27 citations
Semantic Scholar
Double-blind randomized proof-of-concept trial of canakinumab in patients with COVID-19 associated cardiac injury and heightened inflammation
P. Cremer, C. Sheng, D. Sahoo, S. Dugar +13 more
2021European Heart Journal Open24 citations Open access
Semantic Scholar
Prolonged dual antiplatelet therapy after percutaneous coronary intervention reduces ischemic events without affecting the need for repeat revascularization: insights from the CREDO trial.
S. Brener, S. Steinhubl, P. Berger, D. Brennan +1 more
2007The Journal of invasive cardiology19 citations
Semantic Scholar
Risk stratification for patients undergoing nonurgent percutaneous coronary intervention using N-terminal pro-B-type natriuretic peptide: a Clopidogrel for the Reduction of Events During Observation (CREDO) substudy.
W. H. Wilson Tang, S. Steinhubl, F. van Lente, D. Brennan +4 more
2007American Heart Journal19 citations
Semantic Scholar
High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: a substudy from the CHARISMA trial
Michael A. Weber, Deepak L. Bhatt, D. Brennan, G. Hankey +8 more
2011Heart18 citations Open access
Semantic Scholar
Cardiovascular ischemic event rates in outpatients with symptomatic atherothrombosis or risk factors in the united states: insights from the REACH Registry.
K. Eagle, A. Hirsch, R. Califf, M. Alberts +4 more
2009Critical Pathways in Cardiology18 citations Open access
Semantic Scholar
Quantifying harmful effects of psoriatic diseases on quality of life: Cardio-metabolic outcomes in psoriatic arthritis study (COMPASS).
D. Dalal, Yih C. Lin, D. Brennan, Neil Borkar +2 more
2015Seminars in Arthritis & Rheumatism17 citations
Semantic Scholar
Coronary atheroma composition and its association with segmental endothelial dysfunction in non-ST segment elevation myocardial infarction: novel insights with radiofrequency (iMAP) intravascular ultrasonography
R. Puri, S. Nicholls, D. Brennan, J. Andrews +9 more
2015The International Journal of Cardiovascular Imaging12 citations
Semantic Scholar
Use of Sex-Specific Clinical and Exercise Risk Scores to Identify Patients at Increased Risk for All-Cause Mortality
Paul C. Cremer, Yuping Wu, Haitham M. Ahmed, L. Pierson +8 more
2017JAMA cardiology11 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Steinhubl×15
Invite
S. Steinhubl — researcher profile on SciRah
E. Topol×15
Invite
E. Topol — researcher profile on SciRah
Deepak L. Bhatt×11
Invite
Deepak L. Bhatt — researcher profile on SciRah
P. Berger×8
Invite
P. Berger — researcher profile on SciRah

×7

Invite

S. Nissen — researcher profile on SciRah

Invite

L. Cho — researcher profile on SciRah

Invite

S. Hazen — researcher profile on SciRah

Invite

K. Fox — researcher profile on SciRah

Invite

G. Hankey — researcher profile on SciRah

G. Montalescot×5

Invite

G. Montalescot — researcher profile on SciRah

Invite

P. Steg — researcher profile on SciRah

Invite

S. Nicholls — researcher profile on SciRah